Tender Summary: Cell Culture Roller Bottles

Objectives

The primary objective is to secure a qualified supplier capable of delivering high-grade, sterile cell culture roller bottles that meet stringent biomedical, safety, and manufacturing standards. The procuring entity aims to establish a compliant, reliable supply chain for biological product development while adhering to national preferential procurement legislation.

Scope

The tender covers the supply of 80 boxes, each containing 40 cell culture roller bottles (totaling 3,200 units). All deliveries must comply with the Government Procurement General Conditions of Contract. Suppliers must demonstrate a proven track record by providing verifiable evidence of supplying identical goods within the preceding 36 months.

Technical Requirements

• Material & Certification: USP Class VI certified resin; manufactured under cGMP in an ISO 9001 certified facility.
• Device Classification: US Class I 510(k) exempt medical device.
• Capacity & Surface: 850 cm² cell growth area; 2L working volume; tissue culture treated.
• Sterility & Safety: Sterile, pyrogen-tested per ANSI/AAMI ST 72 standards. Bacterial endotoxin acceptance limit: 0.1 EU/mL (4 EU/device).
• Integrity Testing: Forward pressurization validated to 99.06 cm (39 inches) of water column.
• Design & Dimensions: Non-vented, wide-mouth neck with threaded top and easy-grip cap. Height: 271mm; Diameter: 117mm. Features visible black graduations.
• Packaging & Shelf Life: Packaged 2 per pack, 40 per box. Minimum 3-year shelf life from manufacture date.
• Documentation: Certificate of Analysis (CoA) confirming DNase, RNase, pyrogen, and endotoxin-free status. Original manufacturer datasheets, COAs, or complete specification sheets required.

Skills and Supplier Requirements

• Demonstrated commercial experience in supplying regulated biomedical or laboratory equipment within the last three years.
• Ability to compile, verify, and submit comprehensive technical documentation, including manufacturer datasheets and certificates of analysis.
• Working knowledge of international quality, safety, and regulatory frameworks (USP, cGMP, ISO 9001, ANSI/AAMI).
• Competence in preparing fully compliant bid packages that meet all administrative and evidentiary thresholds without omissions.
• Valid Broad-Based Black Economic Empowerment (BBBEE) documentation to substantiate preference point claims.

Evaluation and Compliance Framework

Bids will be evaluated using an 80/20 weighted scoring system: 80% for price and 20% for specific preference goals. Preference points are allocated for historically disadvantaged ownership structures: 10 points for at least 51% black ownership, 8 points for at least 30% women ownership, and 2 points for verified disability ownership. Failure to submit required proof results in immediate disqualification. All bidders must declare compliance with anti-collusion laws, disclose state employment relationships, and adhere to ethical procurement standards.

Explanation of Key Technical and Regulatory Terms

• USP Class VI: The highest plastic material rating by the United States Pharmacopeia, ensuring biocompatibility and safety for direct contact with cells or biological fluids.
• cGMP & ISO 9001: Current Good Manufacturing Practice and an international quality management standard, respectively, guaranteeing consistent production quality, traceability, and risk control.
• ANSI/AAMI ST 72: A recognized industry standard for testing bacterial endotoxins in medical devices to prevent pyrogenic (fever-inducing) reactions in users.
• US Class I 510(k) Exempt: A U.S. Food and Drug Administration classification indicating a low-risk medical device that does not require premarket approval or formal notification due to its minimal hazard profile.
• BBBEE: South Africa’s policy framework designed to redress historical economic inequalities by rewarding companies with diverse ownership structures through preferential procurement scoring.